Venous endothelial dysfunction in Chagas' disease patients without heart failure;Disfunção endotelial venosa em pacientes com doença de Chagas sem insuficiência cardíaca

Arquivos Brasileiros de Cardiologia

Volumn 86, Issue 6, 2006, Pages 466-471

  Plentz, Rodrigo Della Méa ^a,d,e   Irigoyen, Maria Claudia ^b   Muller, Andreia Simone ^a,d   Casarini, Dulce Elena ^a   Rubira, Marcelo Custodio ^b   Moreno Jr , Heitor ^c   Mady, Charles ^b   Ianni, Bárbara Maria ^b   Krieger, Eduardo Moacir ^b   Consolim Colombo, Fernanda ^b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY OF CAMPINAS   (Brazil)

^d UNIVERSIDADE DE CRUZ ALTA   (Brazil)

^e NONE   (Brazil)

Author keywords

Cardiovascular disease; Chagas' disease; Endothelium; System venous

Indexed keywords

ACETYLCHOLINE; NITROPRUSSIDE SODIUM; PHENYLEPHRINE;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CHAGAS DISEASE; CLINICAL ARTICLE; ENDOTHELIAL DYSFUNCTION; FEMALE; HEART FAILURE; HUMAN; MALE; VENOCONSTRICTION;

ACETYLCHOLINE; BLOOD PRESSURE; CASE-CONTROL STUDIES; CHAGAS CARDIOMYOPATHY; ENDOTHELIUM, VASCULAR; FEMALE; HAND; HUMANS; MALE; MIDDLE AGED; NITROPRUSSIDE; PHENYLEPHRINE; VASOCONSTRICTOR AGENTS; VASODILATION; VASODILATOR AGENTS;

EID: 33745878574     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.1590/S0066-782X2006000600009     Document Type: Article

References (39)

1. Schmunis GA, American Trypanosomiasis as a public health problem. In: Pan American Health Organization (ed.) Chagas' Disease and the nervous system. Washington, DC: Pan American Organization; 1994: 3-29.
2. Marin-Neto JA, Simões MV, Sarabanda AV. Chagas'heart disease. Arq Bras Cardiol. 1999; 72: 247-80.
3. Mady C, Barreto AC, Stolf N, Lopes EA, Dauar D, Wajngarten M, et al. Biopsia miocárdica na forma indeterminada da doença de Chagas. Arq Bras Cardiol. 1981; 36: 387-90.
4. Consolim-Colombo FM, Lopes HF, Rosetto EA, et al. Endothelial function is preserved in Chagas' heart disease patients without heart failure. Endothelium. 2004; 11 (5-6): 241-6.
5. Guzman, Juan C, Leon, Hernando, Casa S, Juan P, et al. Disfunción autonómica y vascular en la fase asintomática de la enfermedad de Chagas. Rev Colomb Cardiol. 2004; 11 (2): 105-13.
6. Leiby DA, Rentas FJ, Nelson KE, et al. Evidence of Trypanosoma cruzi infection (Chagas' disease) among patients undergoing cardiac surgery. Circulation. 2000; 102 (24): 2978-82.
7. Moncayo A. Chagas disease: current epidemiological trends after the interruption of vectorial and transfusional transmission in the Southern Cone countries. Mem Inst Oswaldo Cruz. 2003; 5: 577-91.
8. Ramos SG, Rossi MA. Microcirculation and Chagas' disease: hypothesis and recent results. Inst Med Trop São Paulo. 1999; 41 (2): 123-9.
9. Soares Barreto-Filho JA, Consolim-Colombo FM, Ferreira Lopes H, Martins Sobrinho CR, Guerra-Riccio GM, Krieger EM. Dysregulation of peripheral and central chemorefl ex responses in Chagas' heart disease patients without heart failure. Circulation. 2000; 104 (15): 1792-8.
10. Rossi MA, Ramos SG. Coronary microvascular abnormalities in Chagas' disease. Am Heart J. 1996; 132 (1): 207-10.
11. Ianni BM, Arteaga E, Frim CC, Pereira C, Barreto AC, Mady C. Chagas' heart disease: evolutive evaluation of electrocardiographic and echocardiographic parameters in patients with the indeterminate form. Arq Bras Cardiol. 2001; 77: 59-62.
12. Consolim-Colombo FM, Filho JA, Lopes HF, Sobrinho CR, Otto ME, Riccio GM, Mady C, Krieger EM. Decreased cardiopulmonary barorefl ex sensitivity in Chagas' heart disease. Hypertension. 2000; 36 (6): 1035-9.
13. Anderson TJ. Assessment and treatment of endothelial dysfunction in humans. J Am Coll Cardiol. 1999; 34: 631-8.
14. Drexler H, Hornig B. Endothelial dysfunction in human disease Endothelial dysfunction: a novel therapeutic target. Mol Cell Cardiol. 1999; 31: 51-0.
15. Schächinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation. 2000; 101 (16): 1899-6.
16. Rossi MA. Aortic endothelial cell changes in the acute septicemic phase of experimental Trypanosoma cruzi infection in rats: scanning and transmission electron microscopic study. Am J Trop Med Hyg. 1997; 57 (3): 321-7.
17. Camargos ER, Machado CR, Teixeira Jr AL, Rocha LL, Ferreira AJ, Almeida AP, Barton M, Teixeira MM. Role of endothelin during experimental Trypanosoma cruzi infection in rats. Clin Sci (Lond). 2002; 103 (suppl 48): 64S-67S.
18. Morris SA, Tanowitz H, Makman M, Hatcher VB, Bilezikian JP. Trypanosoma cruzi: alteration of cAMP metabolism following infection of human endothelial cell. Exp Parasit. 1992; 74 (1): 69-6.
19. Sunnemark D, Frostegard J, Orn A, Harris RA. Cellular and cytokine characterization of vascular infl ammation in CBA/J mice chronically infected with Trypanosoma cruzi. Scand J Immunol. 1998; 48 (5): 480-4.
20. Tanowitz HB, Wittner M, Morris SA, et al. The putative mechanistic basis for the modulatory role of endothelin-1 in the altered vascular tone induced by Trypanosoma cruzi. Endothelium. 1999; 6 (3):217-0.
21. Cardoni RL, Garcia MM, De Rissio AM. Proinfl ammatory and antiinflammatory cytokines in pregnant women chronically infected with Trypanosoma cruzi. Acta Trop. 2004; 90 (1): 65-2.
22. Ferreira RC, Ianni BM, Abel LC, Buck P, Mady C, Kalil J, Cunha-Neto E. Increased plasma levels of tumor necrosis factor-alpha in symptomatic "indeterminate" and Chagas disease cardiomyopathy patients. Mem Inst Oswaldo Cruz. 2003; 98 (3): 407-1.
23. Malvezi AD, Cecchini R, de Souza F, Tadokoro CE, Rizzo LV, Pinge-Filho P. Involvement of nitric oxide (NO) and TNF-alpha in the oxidative stress associated with anemia in experimental Trypanosoma cruzi infection. FEMS Immunol Med Microbiol. 2004; 41 (1): 69-7.
24. Silva JS, Machado FS, Martins GA. The role of nitric oxide in the pathogenesis of Chagas disease. Front Biosci. 2003; s314-25.
25. Teichholz LE, Kreulen T, Herman MV, Gorlin R. Problems in echocardiographic volume determinations: echocardiographic-angiographic correlation in the present or absence of a synergy. Am J Cardiol. 1976; 37 (1): 7-11.
26. Junqueira Júnior LF; Discriminação entre as manifestações eletrocardiográficas normais, anormais e "borderline" na doença de Chagas. Rev Soc Bras Med Trop. 1992; (Supll III) 25: 83.
27. Chalon S, Bedarida GV, Moreno H Jr, Tejura B, Urae A, Hoffman BB, Blaschke TF. Angiotensin-converting enzyme inhibition improves venous endothelial dysfunction in chronic smokers. Clin Pharmacol Ther. 1999; 65: 295-3.
28. Moreno Jr H, Chalon S, Urae A, Tangphao O, Abiose AK, Hoffman BB, Blaschke TF, Endothelial dysfunction in human hand veins is rapidly reversible after smoking cessation. Am J Physiol. 1998; 275: H1040-5.
29. Sousa MG, Yugar-Toledo JC, Rubira M, et al. Ascorbic acid improves impaired venous and arterial endothelium-dependent dilation in smokers. Acta Pharmacol Sin. 2005; 26 (4): 447-2.
30. Tangphao O, Chalon S, Moreno H, Jr, Hoffman BB, Blaschke TF. Pharmacokinetics of L-arginine during chronic administration to patients with hypercholesterolaemia. Clin Sci (Lond). 1999; 96: 199-7.
31. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980; 288: 373-6.
32. Li H, Forstermann U. Nitric oxide in the pathogenesis of vascular disease. J Pathol. 2000; 190: 244-54.
33. Costa PC, Fortes FS, Machado AB, et al. Sera from chronic chagasic patients depress cardiac electrogenesis and conduction. Braz J Med Biol Res. 2000; 33 (4): 439-46.
34. Masuda MO, Levin M, De Oliveira SF, et al. Functionally active cardiac antibodies in chronic Chagas' disease are specifically blocked by Trypanosoma cruzi antigens. FASEB J. 1998;12 (14):1551-8.
35. Ogawa S, Yoshikawa T. Autoantibodies: emerging upstream targets of arrhythmias and sudden death in patients with idiopathic dilated cardiomyopathy. J Mol Cell Cardiol. 2001; 33 (10): 1761-3.
36. Pedrosa RC. Contribuição ao estudo da etiopatogenia do distúrbio de condução e da eletrogênese na cardiopatia chagásica crônica: efeitos de anticorpos IgG de pacientes chagásicos crônicos na eletrogênese e no sistema de condução do coração isolado de mamíferos. Rio de Janeiro, 1998. Tese (Doutorado) - Universidade Federal do Rio de Janeiro.
37. Schulte KL, Laber E, Meyer-Sabellek WA, Distler A, Gotzen R. Specific alpha-adrenoceptor-mediated vasoconstriction in human veins and interaction with the calcium entry blockers nifedipine and diltiazem. J Hypertens (Suppl). 1985; S239-41.
38. Simões MV, Pintya AO, Bromberg-Marin G, Sarabanda AV, Antloga CM, Pazin-Filho A, Maciel BC, Marin-Neto JA. Relation of regional sympathetic denervation and myocardial perfusion disturbance to wall motion impairment in Chagas' cardiomyopathy. Am J Cardiol. 2000; 86 (9): 975-81.
39. Davila DF, Bellabarba G, Hernandez L, Calmon G, Torres A, Donis JH, Barboza JS, Lemorvan C, Gonzalez JG. Plasma norepinephrine, myocardial damage and left ventricular systolic function in Chagas' heart disease. Int J Cardiol. 1995; 24 52 (2): 145-51.